ÂÜÀòÂÒÂ×

Mr. Bonczek is Chief Financial Officer and a director of Cellective BioTherapy, Inc. He also serves as Chief Administrative Officer at Istari Oncology, Inc. and President and Chief Financial Officer of MedBlue Incubator, Inc. Mr. Bonczek has served as President, Director, CFO, and General Counsel of b3 bio, Inc.; CFO, General Counsel and Chief Administrative Officer of Trimeris, Inc.; and Chief Counsel and Global Director of Safety, Health and Environment, Dupont. Mr. Bonczek is the founding partner, Director, and President of Aspen Tree Capital. He also serves on the boards of several life science-related companies including NeurOp, Inc., Senex Biotechnology, Upstream Therapeutics, Inc., Deep Blue Medical Advances, Inc., Track X Technology, and Istari Oncology, Inc. He is a member of the advisory boards for several companies, including Valence Advantage Life Sciences Fund and Centre Partners. Mr. Bonczek received an AB in chemistry and a JD degree from the University of North Carolina. He also holds an MBA from the Wharton School at the University of Pennsylvania.